Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

Novavax (NASDAQ:NVAX) pivots back to profitability after delivering a $666.7 million revenue haul in Q1surpassing estimates ...

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a type of ovarian cancer ...

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

In the wake of mass restructuring efforts across the Department of Health and Human Services, the FDA has missed yet another ...

BYD, China's No. 1 automaker , aims to sell half of its vehicles outside the Chinese market by 2030, a massive increase that ...

Officials in sixteen states and the District of Columbia sued in response, leading to Tuesday’s order from U.S. District ...

COVID-19 is the disease caused by SARS-CoV-2, the coronavirus that emerged in December 2019. Coronaviruses are a type of virus. There are many different kinds, and some, like COVID-19, cause disease ...